🇺🇸 FDA
Patent

US 11857543

Compositions and methods for treating anemia

granted A61KA61K31/44A61K31/4412

Quick answer

US patent 11857543 (Compositions and methods for treating anemia) held by Akebia Therapeutics, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Akebia Therapeutics, Inc.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/44, A61K31/4412, A61K33/26, A61K38/1816